Provision of full diagnostic histopathology service

Concepts

• pathology services
• taunton
• full diagnostic histopathology service
• a diagnostic histopathology service
• an existing service
• full
• histopathology
• diagnostic
• process c.
• poundbury cancer institute

Location

Taunton

Description

Provision of full diagnostic histopathology service including Her2 Testing, Placenta (wet to report) and SP142/22C3 to support the Trusts Cancer Pathways.

Total Quantity or Scope

This is a direct award to the incumbent supplier, Poundbury Cancer Institute, under the Provider Selection Regime (PSR) using Process C. This is an existing service.The contract is for the provision of a diagnostic histopathology service. The contract term is for one year, from 01/05/2025 to 30/04/2026. The estimated value is £102,047.00.

Award Detail

Award Criteria

CPV Codes

• 85111800 - Pathology services

Indicators

• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 30 April 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.The decision makers were: Service Manager Pathology & End of Life ServicesNo conflicts of interest were declared among decision makers.The key criteria were weighted as follows:50% quality and Innovation10% Value15% Integration, Collaboration and Service Sustainability15% Improving access, reducing health inequalities and facilitating choice10% Social valueThe highest weighting has been applied to quality and innovation as the key objective is maintaining a high-quality service. The other elements of a quality led service have been weighted at 40%. Value in terms of cost has been weighted 10% because maintaining the quality of the service is the main objective of this award. The rationale for choosing the provider with reference to the key criteria:The existing suppliers are experienced services providers with a proven track record, and they are highly likely to be able to satisfy the new contract to a sufficient standard.